Skip to content

4Accepted Jul 12, 4:13 PM ET

Eizen Joshua M 4

ANTXAN2 Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:13 PM

Jul 12, 2024

Filed

Jul 12, 2024

Documents

2

Size

17.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.